Endoradiotherapy with peptides - status and future development.

Area of Science:

• Molecular biology and biochemistry
• Biotechnology
• Radiopharmaceutical therapy

Background:

• Advances in molecular biology have enabled new imaging and treatment modalities.
• Antibodies and peptides are key tools, with peptide vectors showing significant promise.
• Current therapies like chemotherapy and radiation have limitations peptide-based treatments aim to overcome.

Purpose of the Study:

• To focus on the potential of peptide vectors in targeted endoradiotherapy.
• To highlight peptide vectors as a novel class of pharmaceuticals for specific treatments.
• To encourage further research into identifying new specifically binding molecules.

Main Methods:

• Labeling peptide vectors with therapeutic radioisotopes for endoradiotherapy.
• Utilizing structure-activity relationship studies and conformational analyses for rational drug design.
• Employing 'black box' approaches to create and screen large molecular libraries for desired properties.

Main Results:

• Peptide vectors demonstrate targeting potential for highly specific treatments, exemplified by antibodies against CD20 and peptides binding somatostatin receptors.
• These agents are suitable for endoradiotherapy, offering precise targeting.
• Biotechnology methods facilitate the development of new biomolecules.

Conclusions:

• Peptide vectors represent a novel pharmaceutical class with potential for specific therapies exceeding current options.
• The success of current peptide-based targeting serves as proof of principle for further research.
• Both rational design and high-throughput screening are valuable for developing improved peptide therapeutics.